EV/EBITDA:
-11.10+0.39(+3.39%)Summary
- As of today, CRSP EV/EBITDA is -11.10, with a rise of +0.39 (+3.39%) during the current trading session.
- Over the past year, CRSP EV/EBITDA has dropped by -3.20 (-40.51%).
- CRSP EV/EBITDA is now -100.52% below its all-time high of 2142.90.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +3.4% | -3.4% | -2.6% |
| 1M1 Month | -19.6% | +19.7% | +14.3% |
| 3M3 Months | -44.3% | +44.3% | +26.9% |
| 6M6 Months | -210.9% | +199.0% | +85.2% |
| YTDYTD | -192.9% | +186.4% | +77.7% |
| 1Y1 Year | -40.5% | +96.2% | +42.8% |
| 5Y5 Years | +60.8% | -24.6% | -36.3% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -8.58 | -29.4% | -12.52 | +11.3% |
| 3M | 3-Month | -7.21 | -54.0% | -12.52 | +11.3% |
| 6M | 6-Month | -2.69 | -312.6% | -12.52 | +11.3% |
| 1Y | 1-Year | -2.33 | -376.4% | -12.52 | +11.3% |
| 3Y | 3-Year | -2.13 | -421.1% | -33.74 | +67.1% |
| 5Y | 5-Year | 21.60 | -151.4% | -48.40 | +77.1% |
| All-Time | All-Time | 2142.90 | -100.5% | -759.60 | +98.5% |
CRSP EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -11.10(-192.9%) |
| 2024 | -3.79(+80.9%) |
| 2023 | -19.83(-693.2%) |
| 2022 | -2.50(-126.6%) |
| 2021 | 9.40(+133.5%) |
| Date | Value |
|---|---|
| 2020 | -28.06(-151.6%) |
| 2019 | 54.42(+925.8%) |
| 2018 | -6.59(+43.1%) |
| 2017 | -11.59(-59.0%) |
| 2016 | -7.29 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -11.10
What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2142.90
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -7.31 (-192.88%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by -3.20 (-40.51%)